Search - tctmd.com

Displaying 1 - 20 of 20

Sort: Relevancy | Date

News Daily News

Extreme Alcohol Intake Directly Damages the Heart, Study Confirms

Caitlin E. Cox

December 24, 2019

News Daily News

NOBLE at 5 Years: New Data Favor CABG for Left Main Disease

Todd Neale

December 23, 2019

News Daily News

SILVER-AMI Bests GRACE for Predicting 6-Month Mortality After Acute MI in Elderly

L.A. McKeown

December 10, 2019

News Daily News

Repeat Target-Lesion PCI: An Option for Public Reporting?

Michael O'Riordan

October 25, 2019

News Daily News

New-Onset A-fib Tied to Particularly Poor Outcomes After TAVR

Todd Neale

October 18, 2019

News Daily News

German Analysis Supports Long-term Safety of Paclitaxel-Based Therapies

L.A. McKeown

October 09, 2019

News Daily News TCT 2019

BLADE-PCI: Antirestenotic Drug Flops in Diabetics, but Inflammation Hypothesis Lives On

L.A. McKeown

October 02, 2019

News Daily News

Radial PCI Up, but Vascular Complication Rates Haven’t Budged

Yael L. Maxwell

August 29, 2019

News Daily News

Use of IVC Filters for DVT Peaked in 2010 but Remains High

Michael O'Riordan

August 28, 2019

News Daily News

Normal ECG? Artificial Intelligence Disagrees, Spots Signs of A-fib

Marcus A. Banks

August 02, 2019

News Daily News

FDA Advisors Face ‘Forest of Dueling Numbers’ at Paclitaxel PAD Device Review: Day One

L.A. McKeown

June 19, 2019

News Daily News

Warning Signs: Many Cardiac-Arrest Victims Visited Doctors, Emergency Rooms Prior to Events

Yael L. Maxwell

May 10, 2019

News Daily News

Patients Retain Little From Cath Lab Informed-Consent Conversations

Michael O'Riordan

April 26, 2019

News Daily News

Poor Diet Responsible for 11 Million Deaths Annually, With CVD a Leading Cause

Michael O'Riordan

April 04, 2019

News Daily News

No Excess Mortality Risk With Paclitaxel Stents in PAD, Second Medicare Analysis Finds

L.A. McKeown

March 01, 2019

News Daily News

Medicare Analysis Offers More Reassurances in Hullabaloo Over Paclitaxel-Based PAD Devices

L.A. McKeown

February 13, 2019

News Daily News

Aspiration Thrombectomy on the Decline as New Study Affirms No Benefit in STEMI

Michael O'Riordan

January 15, 2019

Febuxostat Emerges Relatively Unscathed After FDA Advisory Committee Vote

News Daily News

Febuxostat Emerges Relatively Unscathed After FDA Advisory Committee Review

Caitlin E. Cox

January 11, 2019

News Daily News

Cancer Patients Should Not Be Automatically Ruled Out for TAVR: Analysis

L.A. McKeown

January 10, 2019

News Daily News

Tailoring Antiplatelet Therapy to Bleeding Risk Post-PCI Improves Outcomes and Cuts Costs, Model Suggests

L.A. McKeown

January 08, 2019

Advertisement

Extreme Alcohol Intake Directly Damages the Heart, Study Confirms

NOBLE at 5 Years: New Data Favor CABG for Left Main Disease

SILVER-AMI Bests GRACE for Predicting 6-Month Mortality After Acute MI in Elderly

Repeat Target-Lesion PCI: An Option for Public Reporting?

New-Onset A-fib Tied to Particularly Poor Outcomes After TAVR

German Analysis Supports Long-term Safety of Paclitaxel-Based Therapies

BLADE-PCI: Antirestenotic Drug Flops in Diabetics, but Inflammation Hypothesis Lives On

Radial PCI Up, but Vascular Complication Rates Haven’t Budged

Use of IVC Filters for DVT Peaked in 2010 but Remains High

Normal ECG? Artificial Intelligence Disagrees, Spots Signs of A-fib

FDA Advisors Face ‘Forest of Dueling Numbers’ at Paclitaxel PAD Device Review: Day One

Warning Signs: Many Cardiac-Arrest Victims Visited Doctors, Emergency Rooms Prior to Events

Patients Retain Little From Cath Lab Informed-Consent Conversations

Poor Diet Responsible for 11 Million Deaths Annually, With CVD a Leading Cause

No Excess Mortality Risk With Paclitaxel Stents in PAD, Second Medicare Analysis Finds

Medicare Analysis Offers More Reassurances in Hullabaloo Over Paclitaxel-Based PAD Devices

Aspiration Thrombectomy on the Decline as New Study Affirms No Benefit in STEMI

Febuxostat Emerges Relatively Unscathed After FDA Advisory Committee Review

Cancer Patients Should Not Be Automatically Ruled Out for TAVR: Analysis

Tailoring Antiplatelet Therapy to Bleeding Risk Post-PCI Improves Outcomes and Cuts Costs, Model Suggests

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content